Stewart Sell completed his graduation from University of Pittsburg. He was appointed as associate professor at University of California and became professor of pathology at University of Texas in the year 1997. In 2003 he became professor of pathology at University of Albany.

Cancer, carcinogenesis, and aging

Dr. Jimmy Efird is an Associate Member of the Leo Jenkins Cancer at Brody School of Medicine. Additionally, he holds a joint appointment as Associate Professor in the Department of Public Health and as Epidemiologist/Chief Statistician (Director, Shared Resources) in the Center for Health Disparities. Dr. Efird received his Ph.D. from Stanford University (Epidemiology with a concentration in Biostatistics). His expertise includes statistical methods for assessing geneenvironment interaction, clinical trial design, computing power and sample size for correlated samples, and multiplicity adjustment for confidence intervals. He has over 100 publications in scientific journals and technical proceedings. Additionally, Dr. Efird serves as a Senior Consultant for The NCRR-funded RCMI Translational Research Network Data and Technology Coordinating Center.

Genetic epidemiology, cancer informatics, brain tumours, soft-tissue sarcomas, and HPV-related cancers.  Additionally, Bioinformatics and Genomics

Anupam Bishayee is the Chair and Associate Professor of Pharmaceutical Sciences, American University of Health Sciences, Signal Hill, CA. His research focuses on elucidation of the cancer preventive and therapeutic effects of medicinal plants, natural products, dietary and synthetic agents using various pre-clinical models of cancer. His ongoing projects are funded by the National Institutes of Health as well as private pharmaceutical/biotechnological institutions. He has published more than 86 original research papers and review articles in high-impact, peer-reviewed journals, 9 book chapters, and presented over 25 papers at various national and international scientific meetings.

Cancer chemoprevention and chemotherapy by dietary agents and phytochemicals, chemoprevention of hepatocarcinogenesis and hepatocellular carcinoma, chemoprevention of mammary carcinogenesis and breast cancer resveratrol and cancer chemoprevention berry and cancer chemoprevention Oxidative stress, inflammation and cancer

Shiaw-Yih Lin has studied DNA damage response in cancer for 10+ years, during which time he has authored more than 40 peer-reviewed reports. He has served on the editorial boards for the World Journal of Clinical Oncology, American Journal of Cancer Research, Frontiers in Molecular and Cellular Oncology, World Journal of Translational Medicine, and Experimental Hematology & Oncology. He is a member of the International Scientific Advisory Board for International Institute of Anticancer Research, and he has served on numerous review committees for the NIH, DOD and Susan G. Komen for the Cure.

Endrometrial Cancer
Breast Cancer Dormancy
Functional and clinical analysis of Rak in breast cancer suppression

Liang Xu is a professor in the Department of Molecular Bioscience in University od Kansas. The goal of the proposed research is to establish nanovectors as a gene/miRNA delivery platform to develop novel molecular therapies targeting cancer stem cells. In summary he has a demonstrated record of successful and productive research projects relevant to the his research field and his expertise and experience have prepared him to go for invention of a new direction in cancer research.

Molecular therapy targeting cancer and cancer stem cells, cancer biology, drug discovery and drug/gene delivery.(Funded by multiple NIH and DOD grants). Molecularly targeted cancer therapy and chemo/radiosensitization by modulating cell death signaling pathways, autophagy and apoptosis. Exploring microRNAs as novel targets for cancer and cancer stem cells. Nanovectors targeting cancer cells for siRNA/miRNA-based novel cancer therapeutics. Nanovectors targeting cancer stem cells and exploring novel molecular therapy for cancer stem cells.

Tumor cell invasion and metastasis, cancer cell metabolism, Cancer cells migrate

Tapan Bera received his M.S. and Ph.D. in Biochemistry from the Calcutta University, India. He completed his postdoctoral research training in the Cancer Research Laboratory, UC Berkeley and in the Laboratory of Molecular Biology, National Cancer Institute. Currently he held the Associate Scientist position at the National Cancer Institute, NIH, USA. His research objectives are focused mainly on to understand the molecular basis of cancer by identifying the genes involved in this process and translate that information to possible targeted therapy of cancer. He has discovered several very interesting and important genes whose expression is restricted to normal prostate and prostate cancer and are now being developed as therapeutic targets for the treatment of prostate cancer. He is author/co-author in more than 65 papers published in peer-reviewed journals.

Cancer biology and Immunotherapy

Yaguang Xi serves as an Assistant Professor of oncologic sciences at the Mitchell Cancer Institute, University of South Alabama, Mobile, Alabama, USA. In 2003, Dr. Xi earned his Ph.D. degree in cancer biology from the Peking University after he accomplished the medical training. His expertise covers molecular biology, cell biology, genomics, genetics, oncology, and bioinformatics. Currently, Dr. Xi focuses on characterizing micro-RNA biomarkers and validating their important roles in cancer development, tumor metastasis, chemotherapy, and prevention.

Cell biology, genomics, genetics, oncology

Reza Hakkak is Professor in the Department of Dietetics and Nutrition, University of Arkansas for Medical Sciences. He is nutritionist, Professor of Pediatrics in the College of Medicine, and Maternal Child Health in the College of Public Health.

Influence of diet and nutrition on cancer prevention, Obesity and Breast Cancer promotion, Animal modeling for Cancer Research, nutrition education, interactions of diet and drug metabolism, and alcohol as a risk factor for cancer development.

Samir A Farghaly is a Physician/Scientist, and faculty member of the Medical College of Cornell University and The New York Presbyterian Hospital /Cornell University Medical Center, New York, NY, USA. He received his M.D Degree from University College London University (1985), and his Ph.D. Degree in molecular biology from London university (1993). He received several clinical and research awards. He has been an invited speaker in several national and international conferences on cancer. He is a member of several national and international societies, organization and foundation of cancer and women health . He is an editor, member of editorial boards and reviewers of several medical journals of Oncology, Gynecology and Gynecological Cancers. He has published 74 articles. He is an editor of a book on ovarian cancer.

Bio markers profile, and screening for ovarian cancer, mutant BRCA1 and BRCA2 genes profiles in ovarian cancer, proteomic profiling of metastatic genes of ovarian cancer, targeted molecular therapy for advanced epithelial ovarian cancer, minimally invasive surgery for gynecological cancer

Kenji Suzuki received his Ph.D. degree in information engineering from Nagoya University in 2001. From 1993 to 2001, he worked at Hitachi Medical Corporation and then Aichi Prefectural University as faculty. In 2001, he joined Department of Radiology at University of Chicago. Since 2006, he has been Assistant Professor of Radiology, Medical Physics and Cancer Research Center there. He has published 200 papers (including 75 peer-reviewed journal papers). He has been serving as the Editor-in-Chief and an Associate Editor of 12 leading international journals including Medical Physics, International Journal of Biomedical Imaging and Academic Radiology. He has received Paul Hodges Award, three RSNA Certificate of Merit Awards and Research Trainee Prize, Cancer Research Foundation Young Investigator Award, SPIE Honorable Mention Poster Award, IEEE Outstanding Member Award and Kurt Rossmann Excellence in Teaching Award. He has been a Senior Member of IEEE since 2004.

Kenji Suzuki areas of expertise are medical image analysis and quantitative imaging.

He was graduated from Tokyo College of Pharmacy. AZer completing his graduate study, he worked on radioactive tracer in drug metabolism as a research assistant at Physical pharmacy department. AZer obtained Ph.D. degree in Pharmaceutical sciences, he joined Dr. Lester Packer’s lab as a post‐doctoral fellow at University of California, Berkeley where he engaged in membrane bioenergetics research on halobacterial rhodopsin. In 1985, he obtained professor position and established radiopharmaceu8cal science lab at Niigata College of Pharmacy where free radical biology and molecular biological researches were developed. 2001, he engaged in establishing Food Science department in NUPALS and started food func8on study using an8oxidant tradi8onal oriental medicine formula as a food model. Current topics of his research are the food func8ons modula8ng DNA damage responses and aging, especially cell cycle checkpoint kinases and their applica8on in Complementary medicine in Cancer treatment. He published more than 150 papers in peer reviewed journal. He served as reviewer, editor of several scien8fic journals and for other social events. He has been chairing Interna8onal Niigata Symposium on Diet and Health since 2004.

Food functions modulating DNA damage responses and aging, especially cell cycle checkpoint kinases and their application in Complementary medicine in Cancer treatment.